Results 151 to 160 of about 8,164,322 (359)

Biologics Used for Psoriasis: A Drug Utilization Study Based on Two Nationwide Danish Data Sources [PDF]

open access: hybrid
Nanna Philbert Engel‐Andreasen   +4 more
openalex   +1 more source

Users of antiasthma drugs in Iceland: a drug utilization study [PDF]

open access: bronze, 1997
T. Gislason, O Olafsson, A Sigvaldason
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital [PDF]

open access: diamond, 2021
Stephin V. Mathew   +5 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Drug utilization study of anti-hypertensive drugs at a tertiary care hospital

open access: diamond, 2020
Pritpal Singh Ahluwalia   +2 more
openalex   +2 more sources

Evaluation of algorithms to identify delirium in administrative claims and drug utilization database

open access: yesPharmacoepidemiology and Drug Safety, 2017
Dae Hyun Kim   +6 more
semanticscholar   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy